Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets
Status:
Terminated
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and find out what effects, good and/or bad,
dabrafenib (a BRAF inhibitor) alone or dabrafenib when given in combination with gamma knife
radiosurgery has on participants with a certain type of skin cancer (BRAFV600E melanoma) and
brain metastases (tumors that have spread to the brain).